Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-19-053570

Chairman and CEO bought 6,500 shares at $2.72 ($17,680)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2019-10-16 Purchase +6,500 $2.72 $17,680 10,258,893 D
Open-market purchases · 6,500 sh · avg $2.72 · $17,680
Loading xslF345X03/doc4.xml…